Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
The Journal of Haemophilia Practice
Volume 5 (2018): Issue 1 (April 2018)
Open Access
Acquired haemophilia A in an elderly patient related to relapsed cervix carcinoma
Fatos Dilan Atilla
Fatos Dilan Atilla
,
Ahmet Alp Unat
Ahmet Alp Unat
,
Hale Bulbul
Hale Bulbul
,
Murat Ulukus
Murat Ulukus
,
Zuhal Demirci
Zuhal Demirci
,
Guray Saydam
Guray Saydam
and
Fahri Sahin
Fahri Sahin
| Dec 14, 2018
The Journal of Haemophilia Practice
Volume 5 (2018): Issue 1 (April 2018)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Case Study
Published Online:
Dec 14, 2018
Page range:
143 - 146
DOI:
https://doi.org/10.17225/jhp00126
Keywords
Acquired haemophilia A
,
bleeding
,
cancer
,
rheumatoid arthritis
© 2018 Fatos Dilan Atilla, Ahmet Alp Unat, Hale Bulbul, Murat Ulukus, Zuhal Demirci, Guray Saydam, Fahri Sahin, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Image: Immunosuppresive treatment of an elderly patient with acquired haemophilia A at Ege University Hospital was potentially complicated by existing corticosteroid treatment for rheumatoid arthritis. However, she responded well to first-line therapy and the underlying cancer it related to was not contraindicated© Shutterstock
Figure 1
Response levels of FVIII and FVIII inhibitor treated with methylprednisolone
Figure 2
Haemoglobin concentration and APTT level during treatment are shown (four units of packed red blood cells were transfused at timeline)